Tirzepatide – 30mg
$150.00
Tirzepatide is a premier, dual-agonist synthetic peptide designed for cutting-edge metabolic research. Targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, this “twincretin” analog is an essential tool for investigating weight regulation, glycemic control, and insulin sensitivity. Each vial is vacuum-sealed and guaranteed at 99% purity, ensuring the highest level of accuracy for in vitro and in vivo longitudinal studies.
8 in stock
Description
Overview of Tirzepatide
Tirzepatide is a sophisticated 39-amino acid synthetic peptide that represents a breakthrough in incretin research. Unlike traditional single-receptor agonists, Tirzepatide’s dual-action mechanism allows researchers to study the synergistic effects of activating two primary metabolic pathways simultaneously. It features a unique C20 fatty-diacid side chain, which provides a significantly extended half-life for extended experimental monitoring.
Key Research Applications
This peptide is at the forefront of metabolic science, specifically used to explore:
-
Dual Incretin Signaling: Researching the combined impact of GIP and GLP-1 receptor activation on cellular signaling and hormone secretion.
-
Metabolic Pathophysiology: Investigating the mechanisms of nutrient-stimulated insulin secretion and the regulation of postprandial glucose levels.
-
Bioenergetics and Adiposity: Studying the compound’s influence on appetite regulation, gastric emptying, and adipose tissue metabolism in animal models.
